Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
1,044.33
+4.33 (0.42%)
Feb 17, 2026, 11:45 AM EST - Market open

Eli Lilly Revenue

In the year 2025, Eli Lilly had annual revenue of $65.18B with 44.70% growth. Eli Lilly had revenue of $19.29B in the quarter ending December 31, 2025.

Revenue (ttm)
$65.18B
Revenue Growth
+44.70%
P/S Ratio
14.32
Revenue / Employee
$1,303,580
Employees
50,000
Market Cap
932.96B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202565.18B20.14B44.70%
Dec 31, 202445.04B10.92B32.00%
Dec 31, 202334.12B5.58B19.56%
Dec 31, 202228.54B223.00M0.79%
Dec 31, 202128.32B3.78B15.40%
Dec 31, 202024.54B2.22B9.95%
Dec 31, 201922.32B826.20M3.84%
Dec 31, 201821.49B1.52B7.61%
Dec 31, 201719.97B-1.25B-5.88%
Dec 31, 201621.22B1.26B6.33%
Dec 31, 201519.96B343.10M1.75%
Dec 31, 201419.62B-3.50B-15.13%
Dec 31, 201323.11B509.70M2.25%
Dec 31, 201222.60B-1.68B-6.93%
Dec 31, 201124.29B1.21B5.25%
Dec 31, 201023.08B1.24B5.68%
Dec 31, 200921.84B1.46B7.19%
Dec 31, 200820.37B1.74B9.33%
Dec 31, 200718.63B2.94B18.75%
Dec 31, 200615.69B1.05B7.14%
Dec 31, 200514.65B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Johnson & Johnson94.19B
Merck & Co.65.01B
Pfizer62.58B
AbbVie61.16B
AstraZeneca58.74B
Novartis AG56.67B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
Revenue Rankings